Effect of Yiqi Tongnao Decoction on Acute Cerebral Infarction of Qi Deficiency and Blood Stasis

Objective: To explore the method and clinical effect of applying Yiqi Tongnao Decoction in the treatment of patients with acute cerebral infarction of Qi deficiency and blood stasis. Methods: To carry out research work in our hospital, a total of 70 patients with acute cerebral infarction of Qi deficiency and blood stasis who were treated in our hospital from March 2018 to March 2019 were randomly divided into two groups, one of which was given Western Medicine as the control group, and the other group was given Yiqi Tongnao Decoction combined with Western medicine, as the research group, the treatment status of the two groups of patients was compared and observed. Results: When comparing, the research group with skewed mouth and eyes, white greasy tongue coating, shortness of breath and fatigue, and pulse fineness scores were lower than those of the control group. The data difference between the groups was shown as P <0.05. The difference between the research group and the control group is quite large. Before treatment, the NIHSS score of the two groups of patients did not change significantly, P> 0.50. After the treatment intervention, the score of the research group was (5.10 ± 1.24), which was lower than that of the control group, and the difference between the groups was P <0.05. Before receiving treatment, there was no significant difference in blood lipid levels between the two groups of patients, P> 0.05. After treatment, the blood lipid level of the two groups of patients both changed, but in contrast, the degree of change in the research group was significantly greater than that of the control group, P <0.05, in general, the treatment effect of the research group was better. Conclusion: In the treatment of patients with acute cerebral infarction of qi deficiency and blood stasis, Yiqi Tongnao Decoction has significant effects, which can effectively improve the patients' adverse symptoms and has positive significance for clinical development.